|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500112702 |
|
最近更新日期: Date of Last Refreshed on: |
2025-11-18 15:32:03 |
|
注册时间: Date of Registration: |
2025-11-18 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
定量Hug-up试验对肩袖全层损伤的评估价值研究 |
|
Public title: |
Diagnostic Value of Quantitative Hug-Up Test for Full-Thickness Rotator Cuff Tear |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
定量Hug-Up试验对肩袖全层损伤的评估价值研究 |
|
Scientific title: |
Diagnostic Value of Quantitative Hug-Up Test for Full-Thickness Rotator Cuff Tear |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
崔胤哲 |
研究负责人: |
崔胤哲 |
|
Applicant: |
Cui Yinzhe |
Study leader: |
Cui Yinzhe |
|
申请注册联系人电话: Applicant telephone: |
+86 188 1065 6701 |
研究负责人电话:
Study leader's |
+86 188 1065 6701 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
cuiyinzhe26@163.com |
研究负责人电子邮件: Study leader's E-mail: |
cuiyinzhe26@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市朝阳区望京中环南路6号 |
研究负责人通讯地址: |
北京市朝阳区望京中环南路6号 |
|
Applicant address: |
No. 6, Wangjing Zhonghuan South Road, Chaoyang District, Beijing |
Study leader's address: |
No. 6, Wangjing Zhonghuan South Road, Chaoyang District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中国中医科学院望京医院 |
||
|
Applicant's institution: |
Wangjing Hospital, China Academy of Chinese Medical Sciences |
||
|
研究负责人所在单位: |
中国中医科学院望京医院 |
||
|
Affiliation of the Leader: |
Wangjing Hospital, China Academy of Chinese Medical Sciences |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
WJEC-YJS-2025-028-P002 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国中医科学院望京医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee, Wangjing Hospital, China Academy of Chinese Medical Sciences |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-07-08 00:00:00 | ||
|
伦理委员会联系人: |
王浩 |
||
|
Contact Name of the ethic committee: |
Wang Hao |
||
|
伦理委员会联系地址: |
北京市朝阳区望京中环南路6号 |
||
|
Contact Address of the ethic committee: |
No. 6, Wangjing Zhonghuan South Road, Chaoyang District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 10 8473 9681 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中国中医科学院望京医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Wangjing Hospital, China Academy of Chinese Medical Sciences |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市朝阳区望京中环南路6号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 6, Wangjing Zhonghuan South Road, Chaoyang District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国中医科学院望京医院 |
||||||||||||||||||||||
|
Source(s) of funding: |
Wangjing Hospital, China Academy of Chinese Medical Sciences |
||||||||||||||||||||||
|
研究疾病: |
肩袖全层损伤 |
||||||||||||||||||||||
|
Target disease: |
Full-Thickness Rotator Cuff Tear |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
开展不少于154例肩痛患者的诊断试验研究,以验证定量Hug-Up试验与肩关节活动度测定在肩袖全层损伤诊断中的评估价值; |
||||||||||||||||||||||
|
Objectives of Study: |
?Conduct a diagnostic trial study with no fewer than 154 patients with shoulder pain to assess the diagnostic value of the quantitative Hug-Up test combined with shoulder range of motion measurement for full-thickness rotator cuff tears.?? |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.患者存在肩痛且症状持续1周以上,病程10年以下且未经治疗者; 2.具备患侧肩关节核磁共振检查结果; 3.言语流利,神志清晰,可准确评价及描述自身不适症状; 4.签署知情同意书,自愿作为受试对象接受治疗者。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Shoulder pain persisting for ≥1 week with symptom duration <10 years and no prior treatment; 2. Availability of MRI results for the affected shoulder; 3. Verbal fluency and clear consciousness enabling accurate symptom reporting 4. Signed informed consent for voluntary trial participation.? |
||||||||||||||||||||||
|
排除标准: |
1.合并有可能引起肩关节疼痛的外部牵扯性疾病;心脏疾病(心绞痛、心肌梗死);上消化道疾病(胆囊炎、胰腺炎、胃食管反流病等);肩关节术后疾病(肩袖修补术后、肩关节置换术后等); 2.合并有心脑血管、肝、肾、造血系统和内分泌系统等严重危及生命的原发性疾病以及精神病; 3.合并有肩关节骨折或脱位类疾病如肩峰骨折、肱二头肌长头腱脱位等; 4.双侧肩关节同时存在不适症状,例如疼痛、活动受限等; 5.妊娠及哺乳期妇女。 |
||||||||||||||||||||||
|
Exclusion criteria: |
?1. Coexisting pathologies causing referred shoulder pain:?? - Cardiac disorders (angina pectoris, myocardial infarction); - Upper gastrointestinal diseases (cholecystitis, pancreatitis, GERD); - Postoperative shoulder conditions (post-rotator cuff repair, shoulder arthroplasty); 2. Life-threatening systemic diseases:?? - Severe primary disorders involving cardiovascular, hepatic, renal, hematopoietic, or endocrine systems; - Psychiatric disorders; 3. Shoulder trauma:?? - Fractures (e.g., acromion fracture) or dislocations (e.g., long head of biceps tendon dislocation); 4. Bilateral shoulder symptoms:?? - Simultaneous pain or functional limitations in both shoulders; 5. Pregnancy or lactation.? |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-07-10 00:00:00至 To 2026-08-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-07-10 00:00:00 至 To 2026-08-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
预计共享的时间为:2025年12月31日,通过临床试验公共管理平台共享数据http://www.medresman.org.cn/ |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Sharing data through a public management platform for clinical trials http://www.medresman.org.cn/ |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集通过病历记录表进行,数据管理通过Excel进行 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection is done through medical record charts and data management is done through Excel |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |